KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Change in Acquisitions & Divestments (2023 - 2025)

Resmed (RMD) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $250000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments changed 0.0% year-over-year to $250000.0, compared with a TTM value of $500000.0 through Dec 2025, down 90.25%, and an annual FY2025 reading of $4.6 million, up 362.8% over the prior year.
  • Change in Acquisitions & Divestments was $250000.0 for Q4 2025 at Resmed, roughly flat from $250000.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $4.1 million in Q3 2024 and bottomed at $250000.0 in Q3 2023.
  • Average Change in Acquisitions & Divestments over 3 years is $1.4 million, with a median of $250000.0 recorded in 2023.
  • The sharpest move saw Change in Acquisitions & Divestments surged 1551.2% in 2024, then tumbled 66.67% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $250000.0 in 2023, then changed by 0.0% to $250000.0 in 2024, then changed by 0.0% to $250000.0 in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for RMD at $250000.0 in Q4 2025, $250000.0 in Q2 2025, and $250000.0 in Q4 2024.